MENU
PLX
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION

Protalix BioTherapeutics (PLX) Earnings Date & Reports

Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx... Show more

A.I. Advisor
published Earnings

PLX is expected to report earnings to fall 320.00% to 10 cents per share on August 18

Protalix BioTherapeutics PLX Stock Earnings Reports
Q2'25
Est.
$0.11
Q1'25
Missed
by $0.08
Q4'24
Est.
$0.10
Q3'24
Missed
by $0.03
Q2'24
Missed
by $0.05
The last earnings report on May 09 showed earnings per share of -5 cents, missing the estimate of 2 cents. With 45.17K shares outstanding, the current market capitalization sits at 121.00M.
View a ticker or compare two or three
PLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of recombinant therapeutic proteins

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Servicestothe Health Industry
Address
2 University Plaza
Phone
+1 201 696-9345
Employees
208
Web
https://www.protalix.com